Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $421.0400 (-1.02%) ($419.6300 - $427.5000) on Tue. Feb. 5, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.09% (three month average) | | RSI | 61 | | Latest Price | $421.0400(-1.02%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.9% a week on average for past two weeks. | | Market Behavior | Growth stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -1.045% in a week (0% probabilities).
UUP(-12%) VXX(-11%) TLT(-6%) IFRA(-5%) XHB(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.045% (StdDev 2.09%) | | Hourly BBV | 0 () | | Intraday Trend | -1.2% | | | | | |
|
| 5 Day Moving Average | $425.15(-0.97%) | | 10 Day Moving Average | $418.88(0.52%) | | 20 Day Moving Average | $412.96(1.96%) | | To recent high | -2.1% | | To recent low | 24.8% | | Market Cap | $44.642b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |